Skip to main content
. 2014 Dec 26;17(4):356–362. doi: 10.4048/jbc.2014.17.4.356

Table 2.

Summary of acute complications of chemotherapy in combination with trastuzumab

graphic file with name jbc-17-356-i002.jpg

AC-TH=doxorubicin with cyclophosphamide followed by paclitaxel and trastuzumab; TCaH=docetaxel, carboplatin, and trastuzumab; TCyH=docetaxel, cyclophosphamide, and trastuzumab; RDI=relative dose intensity.

*Delay ≥7 days due to toxicity; Hospitalization >24 hours; Dose reduction ≥20%.